These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15668105)

  • 1. DNA adduction and mutagenic properties of acrylamide.
    Besaratinia A; Pfeifer GP
    Mutat Res; 2005 Feb; 580(1-2):31-40. PubMed ID: 15668105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage and DNA adduct formation in rat tissues following oral administration of acrylamide.
    Manière I; Godard T; Doerge DR; Churchwell MI; Guffroy M; Laurentie M; Poul JM
    Mutat Res; 2005 Feb; 580(1-2):119-29. PubMed ID: 15668114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adduction of biomacromolecules with acrylamide (AA) in mice at environmental dose levels studied by accelerator mass spectrometry.
    Xie Q; Sun H; Liu Y; Ding X; Fu D; Liu K
    Toxicol Lett; 2006 May; 163(2):101-8. PubMed ID: 16280212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of mechanisms of acrylamide carcinogenicity.
    Besaratinia A; Pfeifer GP
    Carcinogenesis; 2007 Mar; 28(3):519-28. PubMed ID: 17234719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic damage induced by acrylamide and glycidamide in mammalian cells: correlation with specific glycidamide-DNA adducts.
    Martins C; Oliveira NG; Pingarilho M; Gamboa da Costa G; Martins V; Marques MM; Beland FA; Churchwell MI; Doerge DR; Rueff J; Gaspar JF
    Toxicol Sci; 2007 Feb; 95(2):383-90. PubMed ID: 17088317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxicity of acrylamide and glycidamide.
    Besaratinia A; Pfeifer GP
    J Natl Cancer Inst; 2004 Jul; 96(13):1023-9. PubMed ID: 15240786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in toxicology and risk assessment: informing critical dose-response relationships by Swenberg et al., 2008.
    Keshava N; Chen C; White P; Sonawane B; Bussard D
    Chem Res Toxicol; 2009 Jan; 22(1):8-10; author reply 10-2. PubMed ID: 19053183
    [No Abstract]   [Full Text] [Related]  

  • 8. DNA adducts derived from administration of acrylamide and glycidamide to mice and rats.
    Doerge DR; Gamboa da Costa G; McDaniel LP; Churchwell MI; Twaddle NC; Beland FA
    Mutat Res; 2005 Feb; 580(1-2):131-41. PubMed ID: 15668115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
    Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
    Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acrylamide carcinogenicity.
    Klaunig JE
    J Agric Food Chem; 2008 Aug; 56(15):5984-8. PubMed ID: 18624430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxicity study for acrylamide].
    Han JY; Zhang CW
    Wei Sheng Yan Jiu; 2006 Jul; 35(4):513-5. PubMed ID: 16986535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the evidence for genotoxicity of acrylamide (AA), key to risk assessment of dietary AA exposure.
    Eisenbrand G
    Arch Toxicol; 2020 Sep; 94(9):2939-2950. PubMed ID: 32494932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxic effects of acrylamide and glycidamide in mouse lymphoma cells.
    Mei N; Hu J; Churchwell MI; Guo L; Moore MM; Doerge DR; Chen T
    Food Chem Toxicol; 2008 Feb; 46(2):628-36. PubMed ID: 18029077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxicity of acrylamide and its metabolite - glicydamide].
    Pingot D; Pyrzanowski K; Michałowicz J; Bukowska B
    Med Pr; 2013; 64(2):259-71. PubMed ID: 23829070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment of DNA-reactive carcinogens in food.
    Jeffrey AM; Williams GM
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):628-35. PubMed ID: 15990138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
    Doroshyenko O; Fuhr U; Kunz D; Frank D; Kinzig M; Jetter A; Reith Y; Lazar A; Taubert D; Kirchheiner J; Baum M; Eisenbrand G; Berger FI; Bertow D; Berkessel A; Sörgel F; Schömig E; Tomalik-Scharte D
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):433-43. PubMed ID: 19190172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
    Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
    Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblasts.
    Hölzl-Armstrong L; Kucab JE; Moody S; Zwart EP; Loutkotová L; Duffy V; Luijten M; Gamboa da Costa G; Stratton MR; Phillips DH; Arlt VM
    Arch Toxicol; 2020 Dec; 94(12):4173-4196. PubMed ID: 32886187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrylamide and glycidamide: approach towards risk assessment based on biomarker guided dosimetry of genotoxic/mutagenic effects in human blood.
    Baum M; Fauth E; Fritzen S; Herrmann A; Mertes P; Rudolphi M; Spormann T; Zankl H; Eisenbrand G; Bertow D
    Adv Exp Med Biol; 2005; 561():77-88. PubMed ID: 16438290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic consequences of paternal acrylamide exposure and potential for amelioration.
    Katen AL; Roman SD
    Mutat Res; 2015 Jul; 777():91-100. PubMed ID: 25989052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.